$PBIO Pressure BioSciences' Ultra Shear Technology

New Post Public Reply Private Reply Replies (0) Message Board
louied91
221
$PBIO Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market

https://www.accesswire.com/705013/pressure-bi...age-market

Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI's UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages

SOUTH EASTON, MA / ACCESSWIRE / June 14, 2022 / Pressure BioSciences, Inc. (OTCQB BIO) ("PBI" or the "Company" , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and process development services to the worldwide food and beverage, biotherapeutics, and personal wellness industries, among others, today announced a pivotal peer-reviewed scientific publication highlighting the use of PBI's patented Ultra Shear Technology™ ("UST™" platform in the production of protein-enriched milk containing a novel emulsified plant-protein suspension. J.J. Janahar, et al., from The Ohio State University ("Ohio State" College of Food, Agricultural, and Environmental Sciences ("CFAES" in a study published in the high impact journal Food Hydrocolloids, Volume 131, reported that UST successfully created stable suspensions of milk-pea protein blends in microscopic particle sizes - the objective required for commercially-suitable products, and a significant achievement that could not be reached through existing high-pressure processing (HPP) or thermal processing techniques alone.

Efforts to produce satisfying, nutritionally-efficient and sustainable food options are driving one of the fastest growing food and beverage markets worldwide. Creating cost-effective and sustainable food alternatives that appeal to the expectations and preferences of global consumers has pushed researchers to examine many alternative protein enrichment sources, including the use of almonds, oats, soy, coconuts, peas, etc. Unfortunately, many of these protein sources lack the creaminess, texture, sweetness, or other attributes that drive consumer acceptance. The blending of plant and dairy components to achieve the desired consumer appeal presents enormous market opportunities. Pea protein is of particular interest because of its high nutritional value and low cost - but it is highly insoluble in water and thus has been minimally used in protein drinks to date. PBI's proprietary UST platform combines very high pressure and precisely controlled extreme shear forces to provide food scientists the toolset needed to successfully blend dairy and pea protein (two products which naturally resist mixing) into a sensory-appealing, nutritional, and long-term stable plant protein-based beverage.

PBI and Ohio State are co-leading a Food Industry Consortium whose mission is to introduce worldwide food and beverage companies to PBI's UST platform for the production of higher quality, longer shelf-life, and safer liquid foods and beverages. PBI's UST platform is the critical tool that enables and achieves targeted reductions and dependency on chemical additives or damaging heat relied upon in current processing methods. UST is pivotal in enabling the production of natural, organic, healthier, more nutritious, "clean-label" products that offer greater appeal to modern consumers.

Mr. John B. Hollister, Director of Marketing and Sales expanded: "Ohio State and PBI have initiated an aggressive outreach program to a number of preeminent food & beverage companies globally and expect to welcome many Consortium members during the second half of 2022. Members will help direct and focus Ohio State and PBI efforts across a diverse universe of prospective liquid food and beverage products, with emphasis on microbiology, stability, nutrition, sensory qualities, and increased bioavailability. UST applications development will also extend into nutraceutical products, such as infused water, functional sports beverages, and other health-focused products of high interest to consumers and producers." (North Equities Video Interview - Hollister).

Mr. Hollister continued: "With the recent publication of the Ohio State data, an additional and very exciting application of interest is plant protein-based beverages. As new and commercially-relevant UST applications continue to be demonstrated, and Consortium members utilize their first rights to license UST for their own use, Ohio State and PBI will both benefit from resulting royalty streams. PBI will also benefit from equipment leases and consumables sales."

Dr. Edmund Y. Ting, Senior VP of Engineering at PBI, and a pioneer in the development of high pressure-based food technologies, commented: "Many beverage ingredients that are beneficial to convenience, health, and desired sensory characteristics are not soluble in water, e.g., pea proteins. However, UST's ability to achieve micro/nano particle size suspensions of such plant proteins offers enticing solutions for the use of these essential, water-insoluble ingredients. Interestingly, such UST-processed suspensions can be optimized to provide thickening viscosity for certain products, which can result in improved stability, nutritional value, and consumer appeal. Thus, UST's ability to formulate complex micro/nano emulsions and suspensions will give manufacturers multiple additional options for health and wellness products. While we have previously demonstrated that UST makes fantastic nanoemulsions, there are even more applications where microemulsions as well as nano/micro suspensions are practical and useful for products and product concentrates."

Mr. Richard T. Schumacher, President and CEO of PBI, summarized: "The quest for finding alternative beverages that are healthier and environmentally sustainable but also appealing to the palate - such as plant protein-based drinks - is a rapidly growing market estimated to reach $41B by 2027 (MDC Market Report). We are currently in discussions with industry leaders in this market, as well as companies that want to use UST to make high quality nanoemulsions to add vitamins, antioxidants, nutraceuticals, etc. to their beverages. The recent Ohio State results on UST-processed micro/nano plant protein milk suspensions, as well as previously released data om UST-enhanced nanoemulsions, support our confidence that UST has the potential to become an essential tool in future beverage development, as well as in other health-related and consumer markets (TechTalks Video). We continue to look forward to the planned Q3/Q4 2022 commercial release of the UST platform."

Sponsorship of UST development by the U.S. Department of Agriculture's NIFA program is deeply appreciated.

PBI's June 30th Webinar Participation

On June 30th at noon, PBI will participate as an invited panelist in a FORCE Family Office Webinar. Mr. Schumacher will represent PBI. Other panelists are also being invited. The Webinar will be sponsored by FORCE Family Office and will be moderated by Mr. Steven Saltzstein, CEO of FORCE. As further information becomes available, it will be placed on the Force Family Office and Pressure BioSciences websites. If you would like to receive an invitation, please contact us directly.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 90

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Ping An Shows Resilient Growth Amid Economic Pressure

Updated Category News Views 18

Unpacking Ping An's Steady Climb Amid Tumult A few eyebrows might have raised when Ping An Insurance unveiled its nine-month report for 2026. Despite economic turbulence in China—courtesy of a gnarly global scene—the numbers were anything but rattled. Operating profit rose 8.3% year over year to a beefy RMB125,905 million. The equity pool swelled by 4.4% as of...

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 69

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 86

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 98

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 100

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 0

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 14

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 0

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
Digimon Card Game Ventures into Digital Realms

Updated Category News Views 40

A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Ripple Banking License: Unlocking New Opportunities for XRP

Updated Category News Views 129

Ripple Banking License: Unlocking New Opportunities for XRP In recent developments, Ripple is on the brink of obtaining a banking license, a significant milestone that promises to reshape its role within the traditional financial sector. This pivotal moment not only ratifies Ripple’s credibility but also enhances the use of XRP among its holders. The acquisition of a...

Continue Reading
SEI's Dividend: $0.52 a Share May 2026 Call

Updated Category News Views 22

SEI's Dividends Sweeten the Pot In a world where every market shift feels like someone moving your chair just as you sit down, SEI Investments (NASDAQ: SEIC) keeps a consistent beat. They've declared a semi-annual dividend of $0.52 per share, and let me tell you, that's music to any income-seeking investor's ears right now. Those looking for steady returns in this...

Continue Reading
Solana Experiences a Significant Price Surge of 6.18%

Updated Category News Views 48

Solana price jumps 6.18% to $134.95 Solana added 6.18% in the latest session, bringing the price to $134.95. The move points to firm trading momentum as the market keeps a close eye on SOL. Gains like this usually appear when interest broadens and activity picks up, even if the day-to-day path isn’t perfectly smooth. One-week trend: steady gains from $130.33 Beyond the...

Continue Reading
BD Strengthens Future Plans with Strategic Business Separation

Updated Category News Views 1181

BD Announces Strategic Separation of Business Units BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has taken a bold step by announcing a plan to separate its Biosciences and Diagnostics Solutions divisions from the rest of the organization. This strategic separation aims to enhance focus, drive growth, and unlock substantial...

Continue Reading
Understanding Solana's Recent Price Decline and Market Impact

Updated Category News Views 273

Analyzing Solana's Price Drop In the last day, Solana has encountered a significant decrease in its price, falling by more than 9% and currently valued at $120.87. This price drop is part of a broader downward trend observed over the past week, where the cryptocurrency recorded a staggering loss of 22%. The decline in value from $157.77 to its present figure illustrates...

Continue Reading